NAT statement on universal availability to HIV prevention medication PrEP

NAT statement on universal availability to HIV prevention medication PrEP

Publication date

Friday, October 4, 2019

NAT statement on universal availability to HIV prevention medication PrEP

Kat Smithson, Director of Policy at (National AIDS Trust), said:

“NAT stands alongside the doctors who deliver the services to provide PrEP, in calling for it to be universally available to all who need it.”

HIV prevention drug PrEP available on the NHS from September

HIV prevention drug PrEP available on the NHS from September

Publication date

Thursday, August 3, 2017

NHS England has announced that from September pre-exposure prophylaxis (PrEP) will be available through the NHS as part of a three-year trial. This announcement comes a year and a day after an historic win for NAT (National AIDS Trust) at the High Court that confirmed the NHS’s legal ability to fund the drug, which stops people from getting HIV.

Exposed: HIV prevention funding cut by a third in areas with crucial need

Exposed: HIV prevention funding cut by a third in areas with crucial need

Publication date

Tuesday, June 27, 2017

Data published today by NAT (National AIDS Trust), shows a significant decrease in spending on HIV prevention across the UK. In areas with a high HIV prevalence, where need is highest, spending dropped by 29% in two years. In London, where all 32 boroughs have a high prevalence of HIV, there was a 35% reduction in HIV prevention funding.

Scotland first in UK to approve anti-HIV drug

Scotland first in UK to approve anti-HIV drug

Publication date

Monday, April 10, 2017

JOINT PRESS RELEASE

Scotland first in UK to approve anti-HIV drug 

Today (Monday 10th April) Scotland becomes the first of the UK nations to approve the provision of PrEP (Pre Exposure Prophylaxis) by the NHS to prevent HIV.

Following a rigorous process the Scottish Medicines Consortium (SMC) today announced that PrEP, the HIV prevention drug, has been deemed a cost-effective treatment to prevent the transmission of HIV and will be made available on the NHS in Scotland.

National HIV Prevention: Hurray for the £1.2 million

National HIV Prevention: Hurray for the £1.2 million

Part One. Just before the Christmas holidays Public Health England (PHE) released their tender documentation for a new national HIV prevention programme, to last for three years from 2016/17, with the possibility of extensions for a maximum of a further two years.

Part 2: National HIV Prevention: Where's the £1.2m?

Part 2: National HIV Prevention: Where's the £1.2m?

In my last blog I welcomed PHE’s new tender for a national HIV prevention programme. The annual value of the programme is £1.2 million, the same as the value for HIV Prevention England in 2015/16. In the current context of significant cuts to the public health budget announced by the Chancellor in his Spending Review, to maintain the programme’s value is an achievement, and absolutely necessary given experts agree that HIV incidence is increasing.

National HIV prevention - grateful for small mercies?

National HIV prevention - grateful for small mercies?

Some readers will recall the campaign NAT led at the end of 2014 to prevent national HIV prevention spending being cut by 50%. We were successful – and last year in 2015/16 the overall amount spent by central government remained more or less stable at £2.4 million. But what now are the plans for the current year, 2016/17? NAT wrote to Public Health England (PHE) to find out. One thing is clear… not enough is being done in England to prevent HIV transmissions.